Ticker Launch

SPAC · Merger completed

Voyager Acquisition Corp.

Business combination with Veraxa Biotech AG

Voyager Acquisition Corp. is a blank-check company (SPAC) that raised $220M in its initial public offering on Aug 12, 2024, listing on Nasdaq Global Market. It completed its business combination with Veraxa Biotech AG on Jun 16, 2026; the combined company is Veraxa Biotech Holding AG. Winston & Strawn advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.

Status
Merger completed
IPO date
Aug 12, 2024
IPO size
$220M
IPO exchange
Nasdaq Global Market
Target
Veraxa Biotech AG
Announced
Apr 23, 2025
Closed
Jun 16, 2026
Combined company
Veraxa Biotech Holding AG
SPAC counsel (IPO)
Winston & Strawn and Appleby
Underwriters' counsel (IPO)
Ellenoff Grossman & Schole

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2026